New Key Statistics Module, Z-Score and F-Score
SZSE:300972 Key Ratios
Market Cap ¥ M | 10,203.72 |
Enterprise Value ¥ M | 9,527.67 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 24.11 |
Price/Book | 10.85 |
Price/Sales | 0.51 |
Price/Free Cash Flow | 6.62 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 17,992.00 |
EPS (TTM) ¥ | -0.50 |
Beneish M-Score | 0.31 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -8.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 34.69 |
EV-to-EBITDA | 34.69 |
PEG | -- |
Shares Outstanding M | 179.48 |
Net Margin (%) | -0.43 |
Operating Margin % | 1.77 |
Pre-tax Margin (%) | 1.29 |
Quick Ratio | 0.84 |
Current Ratio | 1.11 |
ROA % (ttm) | -2.14 |
ROE % (ttm) | -9.95 |
ROIC % (ttm) | 3.43 |
Dividend Yield % | -- |
Altman Z-Score | 5.39 |
SZSE:300972 Number of Guru Trades
SZSE:300972 Volume of Guru Trades
Gurus Latest Trades with SZSE:300972
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300972 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fujian Wanchen Biotechnology Group Co Ltd Insider Transactions
No Available Data